CD34 and neoplasm: In addition, qPCR confirmed that the CD34− tumor cells express negligible levels of CD115 compared to the TAMs (Supplemental Figure S1F), and CD115 immunolabeling within tumor sections was accordingly restricted to immune cells (Supplemental Figure S1G).